Search

everythinglearnresearchcommunity

for

Search:↓

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Thyroid function affects skin health, with a complex interaction between the two.

Trichohyalin is also found in the outer layers of normal human skin.

A new hydrogel with stem cells from human umbilical cords improves skin wound healing and reduces inflammation.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Activin B improves wound healing and hair growth by helping stem cells move using certain cell signals.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Stem cell therapy may help treat tough hair loss cases.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.